8/106 sources · 5 publishersUpdated Nov 13, 14:39 UTC
vVardis raises $175 million in NYSE IPO
+4 new sources since this summary was written
vVardis priced 9.72 million shares at $18 each, raising $175 million and will list on the New York Stock Exchange under the ticker VVVV. Co‑founders and co‑CEOs Dr. Haley Abivardi and Dr. Goly Abivardi announced the public offering. The IPO was highlighted in a NYSE pre‑market advisory on 13 Nov 2026.
Why it matters
The IPO adds a new dental‑health company to the NYSE, creating a fresh tradable security for investors. The $175 million proceeds provide vVardis with capital to fund product development and commercial rollout.
Key facts
- 1vVardis raised $175 million in its IPO. prnewswire.com
- 2The company priced 9.72 million shares at $18 per share. prnewswire.com
- 3vVardis will list on the NYSE under the ticker symbol VVVV. prnewswire.com
- 4Co‑founders, Co‑Chairs and Co‑CEOs Dr. Haley Abivardi and Dr. Goly Abivardi led the announcement. prnewswire.com
- 5The IPO was announced in a NYSE pre‑market daily advisory on 13 Nov 2026. finanznachrichten.de
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.